Viral infection and asthma: Respiratory syncytial virus and wheezing illness

Allergology International

Volumn 48, Issue 2, 1999, Pages 93-101

  Ichinohe, Sadato ^a,b   Chida, Shoichi ^a   Inoue, Hiroshi ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Asthma; Bronchiolitis; Chemokine; Eosinophil cationic protein; RANTES (regulated: upon activation, normal T cell expressed and presumably secreted); Respiratory syncytial virus

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHEMOKINE; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; RANTES; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RIBAVIRIN; UNCLASSIFIED DRUG; VIAZOLE; VIRUS ANTIGEN;

ASTHMA; BRONCHIOLITIS; CHILDHOOD DISEASE; CLINICAL TRIAL; EOSINOPHIL; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFLAMMATION; REVIEW; VIRUS INFECTION; VIRUS TRANSMISSION; WHEEZING;

EID: 0033583570     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1592.1999.00126.x     Document Type: Review

References (75)

1. Sly RM. Asthma. In: Behrman RE, Kliegman RM, Arvin AM, (eds). Nelson Textbook of Pediatrics, 15th edn. Philadelphia: WB Saunders, 1996; 628-41.
2. Sluiter HJ, Koeter GH, de Monchy JG, Postma DS., de Vries K, Orie NG. The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur. Respir. J. 1991; 4: 479-89.
3. Minor TE, Dick EC, DeMeo AN, Ouellete JJ, Cohen M, Reed CE. Viruses as precipitants of asthmatic attacks in children. JAMA 1974; 227: 292-8.
4. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310: 1225-9.
5. Phelan PD, Olinsky A, Robertson CF. The epidemiology of acute respiratory infections. In: Phelan PD, Olinsky A, Robertson CF (eds). Respiratory Illness in Children, 4th edn. Oxford: Blackwell Science, 1994; 27-51.
6. Webb MS, Henry RL, Milner AD, Stokes GM, Swarbrick AS. Continuing respiratory problems three and a half years after acute viral bronchiolitis. Arch. Dis. Child. 1985; 60: 1064-7.
7. Sims DG, Downham MA, Gardner PS, Webb JK, Weightman D. Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy. BMJ 1978; 1: 11-14.
8. Horowitz L. Bronchiolitis and asthma. Pediatrics 1967; 40: 693-4.
9. Landau LI. Respiratory infections and wheezing in children. Curr. Opin. Pediatr. 1996; 8: 3-5.
10. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. N. Engl. J. Med. 1995; 332: 133-8.
11. Morris JA, Blount Jr RE, Savage RE Recovery of cytopathogenic agent from chimpanzees with coryza. Proc. Soc. Exp. Boil. Med. 1956; 92: 544-9.
12. Collins PL, Huang YT, Wertz GW. Identification of a tenth mRNA of respiratory syncytial virus and assignment of polypeptidesto the 10 viral genes. J. Viorl. 1984; 49: 572-8.
13. Hall CB, Douglas Jr RG. Modes of transmission of respiratory syncytial virus. J. Pediatr. 1981 ; 99: 100-3.
14. Report to the Medical Research Council Subcommittee on Respiratory Syncytial Virus Vaccines. Respiratory syncytial infection: Admission to hospital in industrial, urban and rural area. BMJ 1978; 2: 796-8.
15. Hemming VG. Viral respiratory disease in children: Classification, etiology and risk factors. J. Pediatr. 1994; 124: S13-16.
16. MacDonald NE, Hall CB, Suffin SC, Alexson C, Harris PJ, Manning JA. Respiratory syncytial viral infection in infants with congenital heart disease. N. Engl. J. Med. 1982; 307: 397-400.
17. Groothuis JR, Gutierrez KM, Lauer BA. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 1988; 82: 199-203.
18. Hall CB, Powell KR, MacDonald NE et al. Respiratory syncytial virus infection in children with compromised immune function. N. Engl. J. Med. 1986; 315: 77-81.
19. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus Am. J. Dis. Child. 1986; 140: 543-6.
20. Beem M. Repeated infections with respiratory syncytial virus. J. Immunol 1967; 98: 1115-22.
21. Orenstein DM. Bronchiolitis In: Behrman RE, Kliegman RM, Arvin AM (eds). Nelson Textbook of Pediatrics, 15th edn. Philadelphia: WB Saunders, 1996; 1211-13.
22. Miller ME Immunodeficiencies of immaturity. In: Stiehm ER (ed.). Immunologic Disorders in Infants and Children, 3rd edn. Philadelphia: WB Saunders, 1989; 196-225.
23. Inselman LS, Mellins RB. Growth and development of the lung. J. Pediatr. 1981; 98: 1-15.
24. Hall CB. Respiratory syncytial virus. In: Feign D, Cherry JD (eds). Textbook of Pediatric Infectious Disease. Philadelphia: WB Saunders, 1992; 1633-56.
25. Neilson KA, Yunis EJ. Demonstration of respiratory syncytial virus in an autopsy series. Pediatr. Pathol. 1990; 10: 491-502.
26. 2-agonist in bronchiolitis: A reappraisal and meta-analysis. Pediatrics 1997; 100: 233-9.
27. Walker TA, Khurana S, Tilden SJ, Viral respiratory infections. Pediatr. Clin. North Am. 1994; 41: 1365-81.
28. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. Bethesda: National Asthma Education and Prevention Program, 1997; Publication No. 97-4051.
29. Hall CB, McBride JT, Walsh EE et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. N. Engl. J. Med. 1983; 308: 1443-7.
30. Kim HW, Canchola JG, Brandt CD et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 1969; 89: 422-34.
31. Hall CB. Prospects for a respiratory syncytial virus vaccine. Science1994; 265: 1393-4.
32. Meissner HC, Fulton DR, Groothuis JR ef al. Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin. Antimicrob. Agents Chemother. 1993; 37: 1655-8.
33. Groothuis JR, Simoes EA, Levin MJ et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N. Engl. J Med. 1993; 329: 1524-30.
34. Everitt DE, Davis CB, Thompson K ef al. The pharmacokinetics, antigenicity and fusion-inhibition activity of RSHZ19, a humanized monoclonal antibody to respiratory syncytial virus, in healthy volunteers. J. Infect. Dis. 1996; 174: 463-9.
35. A report of the conclusions of a CIBA Guest Symposium. Terminology, definitions, and classifications of chronic pulmonary emphysema and related conditions. Thorax 1959; 14: 286-99.
36. Expert Panel Report I: Guidelines for the Diagnosis and Management of Asthma. Bethesda: National Heart, Lung and Blood Institute, 1991; Publication No. 91-3642.
37. Dunnill MS. The pathology of asthma with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 1960; 13: 27-33.
38. Filley WV, Holley KE, Kephart GM, Gleich GJ. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet 1982; ii: 11-16.
39. Bousquet J, Chanez P, Lacosre JY et al. Eosinophilic inflammation in asthma. N. Engl. J. Med. 1990; 323: 1033-9.
40. Kelso A. Th1 and Th2 subsets: Paradigms lost? Immunol. Today 1995; 16: 374-9.
41. Openshaw PJM, O'Donnell DR. Asthma and the common cold: Can viruses imitate worms? Thorax 1994; 49: 101-3.
42. Walsh GM, Wardlaw AJ. Eosinophils. In: Stockley RA (ed.). Pulmonary Defences. Chichester: John Wiley & Sons, 1997; 127-47.
43. Corne JM, Holgate ST. Mechanisms of virus induced exacerbations of asthma. Thorax 1997; 52: 380-9.
44. Anderson LJ, Tsou C, Potter C et al. Cytokine response to respiratory syncytial virus stimulation of human blood mononuclear cells. J. Infect. Dis. 1994; 170: 1201-8.
45. Ward BJ, Griffin DE. Changes in cytokine production after measles virus vaccination: Predominant production of IL-4 suggests induction of a Th2 response. Clin. Immunol. Immunopathol. 1993; 67: 171-7.
46. Hussell T Spender LC, Georgiou A, O'Garra A, Openshaw PJM. Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus. J. Gen. Virol. 1996; 77: 2447-55.
47. + T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 1997; 27: 3341-9.
48. Noah TL, Becker S, Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am. J. Physiol. 1993; 265: L472-8.
49. Arnold R, Humbert B, Werchau H, Gallati H, Koenig W. Interleukin-8, interleukin-6 and soluble tumor necrosis factor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 1994; 82: 126-33.
50. Becker s, Reed W, Henderson FW, Noah TL. RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES. Am. J. Physiol. 1997; 272: L512-20.
51. Saito T, Deskin RW, Casola A et al. Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J. Infect. Dis. 1997; 175: 497-504.
52. Alam R, Stafford S, Forsythe P ef al. RANTES is a chemotactic and activating factor for human eosinophils. J. Immunol. 1993; 150: 3442-8.
53. Olszewska B, Mei F, Ogra PL, Garofalo RP. Respiratory syncytial virus-infected airway epithelial cells induce transendothelial migration of human blood eosinophils J. Allergy Clin. Immunol. 1996; 97: 283.
54. Baggiolini M, Dahinden CA. CC chemokines in allergic inflammation. Immunol. Today 1994; 15: 127-33.
55. Noah TL, Henderson FW, Henry MM, Peden DB, Devlin RB. Nasal lavage cytokines in normal, allergic, and asthmatic school-age children. Am. J. Respir. Crit. Care Med. 1995; 152: 1290-6.
56. Chanez P, Enander I, Jones I, Godard P, Bousquet J. Interleukin 8 in bronchoalveolar lavage of asthmatic and chronic bronchitis patients. Int. Arch. Allergy Immunol. 1996; 111: 83-8.
57. Bischoff SC, Krieger M, Brunner T et al. RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur. J. Immunol. 1993; 23: 761-7.
58. Einarsson O, Geba GP, Zhu Z, Landry M, Elias JA. Interleukin-11: Stimulation In vivo and In vitro by respiratory viruses and induction of airways hyperresponsiveness. J. Clin. Invest. 1996; 97: 915-24.
59. Elias JA, Zheng T, Einarsson O et al. Epithelial interleukin-11: Regulation by cytokines, respiratory syncytial virus and retinoic acid. J. Biol. Chem. 1994; 269: 22 261-8.
60. Graham BC, Henderson GS, Tang YW, Lu X, Neuzil KM, Colley DG. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 1993; 151: 2032-40.
61. Srikiatkhachorn A, Braciale TJ. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection. J. Virol. 1997; 71: 678-85.
62. Alwan WH, Record FM, Openshaw PJM. Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins. J. Imunol. 1993; 150: 5211-18.
63. Openshaw PJM. Immunopathological mechanisms in respiratory syncytial virus disease. Springer Semin. Immunopathol. 1995; 17: 187-201.
64. Openshaw PJM, Hussell T. The effect of IL-12 treatment on vaccine-enhanced illness during infection with respiratory syncytial virus. In: Brown F; Haaheim LR (eds). Modulation of the Immune Response to vaccine Antigens. Dev. Biol. Stand. Basel: S. Karger, 1998; 92: 179-85.
65. Hall SS. IL-12 at the crossroads. Science 1995; 268: 1432-4.
66. Welliver RC, Kaul TN, Ogra PL. The appearance of cellbound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection. N. Engl. J. Med. 1980; 303: 1198-202.
67. Welliver RC, Duffy L. The relationship of RSV-specific immunoglobulin E antibody response in infancy, recurrent wheezing, and pulmonary function at age 7-8 years. Pediatr. Pulmonol. 1993; 15: 19-27.
68. Welliver RC, Wong DT, Middleton Jr E, Sun M, McCarthy N, Ogra PL. Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J. Pediatr. 1982; 101: 889-96.
69. Volovitz B, Welliver RC, De Castro G, Krystofik DA, Ogra PL. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: Role in obstructive airway disease. Pediatr. Res. 1988; 24: 504-7.
70. Garofalo R, Welliver RC, Ogra PL Concentration of LTB4, LTC4, LTD4, and LTE4 in bronchiolitis due to respiratory syncytial virus. Pediatr. Allergy Immunol. 1991; 2: 30-7.
71. Garofalo R, Kimpen JLL, Welliver RC, Ogra PL. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection, J. Pediatr. 1992; 120: 28-32.
72. Colocho Zelaya EA, Orvell C, Strannegard O. Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus. Pediatr. Allergy Immunol. 1994; 5: 100-6.
73. Ingram JM, Rakes GP, Hoover GE, Platts-Mills TA, Heymann PW. Eosinophil cationic protein in serum and nasal washes from wheezing infants and children. J. Pediatr. 1995; 127: 558-64.
74. Ichinohe S, Kobayashi H, Ichinohe N, Fujiwara T, Yamauchi K, Inoue H. Not Th2 lymphocyte-derived cytokines, but RANTES production is a possible mechanism of eosinophil infiltration in respiratory tract of infants with viral bronchiolitis. Am. J. Respir. Crit Care Med. 1997: 155: A521.
75. Ichinohe S, Kobayashi H, Ichinohe N et al. Interleukin-12 (IL-12) decrease eosinophil infiltration in respiratory tract of infant with viral bronchiolitis. Am. J. Respir. Crit. Care Med. 1998; 157: A287.